Eastman 3rd Quarter 2026 Sales and Earnings Results Conference Call - EASTMAN CHEMICAL CO

Financial Performance:

• Advanced Materials (AM) and Acetyl Products (AFP) segments on track for record earnings in 2026, driven by successful price increases implemented to offset raw material inflation.
• Full-year 2026 adjusted operating cash flow guidance lowered from $900 million to $850 million due to working capital buildup ($560 million) linked to inflationary pressures and the Iran conflict; a significant release is expected in Q4 and 2027.
• Advanced Materials faces an estimated $30 million full-year headwind in price-cost spreads, with roughly half ($15 million) concentrated in Q4 due to elevated Paraxylene (PX) costs.
• Acetate (Fibers) segment experienced mid-single-digit price degradation in 2025 due to open contracts and textile demand weakness, though volumes remained stable.
• Inventory levels (Days Inventory Outstanding) decreased from 115 days at year-end 2025 to approximately 105 days in Q3, with reduction opportunities identified in Advanced Materials and Fibers.

Guidance and Future Outlook:

• Circular Economy (Recycled PET and Triton) revenue is projected to reach up to $100 million in 2026, with a minimum of $100 million expected in 2027 as capacity expands.
• 2026 full-year volume/mix growth for Advanced Materials is guided at approximately 3%, driven by innovation and market share gains despite headwinds in China's performance film sector.
• 2027 outlook anticipates volume growth in AM, AFP, and Fibers, alongside improved asset utilization and a return to normalized spreads in the Chemical Intermediates (CI) segment.
• Management expects 2027 earnings to remain stable relative to 2026, supported by working capital releases and volume expansion, despite potential mid-single-digit price declines in Acetate.
• The Metathesis (E2P) project is targeted for mid-2028 completion, expected to generate ~$100 million in annual earnings and reduce earnings volatility.

Business Segments and Product Lines:

• Circular Program: Q3 saw delays in Triton and polymer line startups (approx. 1 month) due to pump failures and conversion issues; both lines are now operational with no impact expected in Q4.
• Advanced Materials: Strong performance in interlayer innovation (HUD, EV applications) offset by destocking in China's mid-tier market; performance films faced margin compression but saw Q3 improvements.
• Acetate Products: Low-cost leader status maintained via Kingsport integration; strategy involves regaining market share as competitors face destocking pressures.
• Acetyl Products (AFPs): Functional materials and specialty businesses driving record performance; agricultural markets expected to be stable in 2027.

Market and Competitive Landscape:

• Chemical Intermediates: Propylene-Propane spread anomaly (20-cent arbitrage between US and China) is viewed as temporary; expected to close as supply constraints and margin compression force Asian production cuts.
• Strategic Alliances: DOE grant reinstatement validates US supply chain re-industrialization; alignment with government goals on material security, particularly for PET against Chinese dominance.
• Competitor Activity: Recent M&A in Acetate (Genon-Sirdia) expected to increase capacity but focus on cost synergies rather than new capacity additions, potentially stabilizing the industry.
• Japanese Competitors: No material capacity expansions expected from Japanese rivals in interlayer markets due to weak demand.

Risks and Challenges:

• Geopolitical: Escalation of the Iran conflict causing volatile raw material costs (PX, oil) and supply chain disruptions, impacting Q4 margins and working capital.
• Operational: Startup delays at Kingsport and Triton lines caused temporary volume misses and cost overruns in Q3; planned turnarounds pushed to Q4.
• Market: Persistent stagflation, high interest rates, and weak auto/construction demand in the US, China, and Europe suppressing end-market growth.
• Regulatory/Environmental: Dependence on government grants (DOE) which cover 30-50% of specific circular project capex, requiring matching investment.

Management Commentary and Tone:

• Tone: Cautiously optimistic; management emphasizes resilience, successful commercial execution, and the strategic value of the DOE grant despite macro headwinds.
• Capital Discipline: Commitment to disciplined capex allocation ($400M in 2026, baseline ~$500M in 2027) to preserve cash flow and liquidity while pursuing high-return projects.
• Confidence: Strong belief in the ability to pass through costs in stable markets and regain share in Acetate through pricing discipline and inventory adjustments.

Analyst Questions and Answers:

• DOE Grant Allocation: Grant covers 50% of capex for Kingsport expansion and infrastructure, including bottleneck removal and feedstock processing, not just the new plant; second plant expected to be more capital efficient ($100k ton vs $130k ton output).
• Q4 Volume Drivers: High single-digit Q4 volume growth expected to compensate for Q3 misses, driven by momentum in Circular, innovation in durables, and stabilization in performance films.
• Capex Trajectory: 2027 capex remains "in plan" ($400M-$500M range); DOE grant reduces effective net spend, allowing for continued investment in Circular and Metathesis without compromising financial discipline.
• Metathesis Economics: Project has a 1-2 year payback; doubling the scale from original intent creates significant value while mitigating volatility from bulk ethylene sales.
• Acetate Pricing: 2027 expected to see mid-single-digit price declines but volume recovery as destocking concludes and new contracts reset at lower levels; earnings stability is the primary goal.

Other Key Points:

• The E2P (Metathesis) project replaces a cracker rather than building a new one, significantly enhancing capital efficiency.
• Management distinguishes between "primary demand" and customer inventory management, noting customers are more cautious due to geopolitical uncertainty than actual end-market consumption.
• The $15 million Q4 headwind in price-cost is a swing from the previously anticipated tailwind, largely due to sustained high PX prices.
• Eastman's integration and scale provide a distinct cost advantage in the Acetate sector, allowing them to weather price competition better than less integrated peers.